Induction of the Liver Cancer-down-regulated Long Noncoding RNA Uc002mbe.2 Mediates Trichostatin-induced Apoptosis of Liver Cancer Cells

Overview

Journal Biochem Pharmacol

Specialties Biochemistry
Pharmacology

Date 2013 May 7

PMID 23643933

Citations 27

Authors

Hui Yang

Yun Zhong

Hui Xie

Xiaobo Lai

Miqing Xu

Yuqiang Nie

Shiming Liu

Yu-Jui Yvonne Wan

Affiliations

Soon will be listed here.

Abstract

Differential expression of long non-coding RNAs (lncRNAs) plays critical roles in hepatocarcinogenesis. Considerable attention has focused on the antitumor effect of histone deacetylase inhibitor (Trichostatin A, TSA) as well as the coding gene expression-induced apoptosis of cancer cells. However, it is not known whether lncRNA has a role in TSA-induced apoptosis of human hepatocellular carcinoma (HCC) cells. The global expression of lncRNAs and coding genes was analyzed with the Human LncRNA Array V2.0 after 24 h treatment. Expression was verified in cell lines and tissues by quantitative real-time PCR. The data showed that 4.8% (959) of lncRNA and 6.1% (1849) of protein coding gene were significantly differentially expressed. The differential expressions of lncRNA and protein coding genes had distinguishable hierarchical clustering expression profiling pattern. Among these differentially expressed lncRNAs, the greatest change was noted for uc002mbe.2, which had more than 300 folds induction upon TSA treatment. TSA selectively induced uc002mbe.2 in four studied HCC cell lines. Compared with normal human hepatocytes and adjacent noncancerous tissues, uc002mbe.2 expression level was significantly lower in the HCC cell lines and liver cancer tissues. The TSA-induced uc002mbe.2 expression was positively correlated with the apoptotic effect of TSA in HCC cells. In addition, knockdown the expression of uc002mbe.2 significantly reduced TSA-induced apoptosis of Huh7cells. Therefore, TSA-induced apoptosis of HCC cells is uc002mbe.2 dependent and reduced expression of uc002mbe.2 may be associated with liver carcinogenesis.

Citing Articles

The expression and function of long noncoding RNAs in hepatocellular carcinoma.

Du J, Su Y, Gao J, Tai Y Cancer Innov. 2023; 2(6):488-499.

PMID: 38125766 PMC: 10730004. DOI: 10.1002/cai2.90.

Long Non-coding RNA LOC285194 Promotes Epithelial Ovarian Cancer Progression the Apoptosis Signaling Pathway.

Yim G, Lee D, In Kim J, Kim Y In Vivo. 2022; 36(1):121-131.

PMID: 34972707 PMC: 8765146. DOI: 10.21873/invivo.12683.

Detecting lncRNA-Cancer Associations by Combining miRNAs, Genes, and Prognosis With Matrix Factorization.

Yan H, Chai H, Zhao H Front Genet. 2021; 12:639872.

PMID: 34262591 PMC: 8273282. DOI: 10.3389/fgene.2021.639872.

Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance.

Shafabakhsh R, Arianfar F, Vosough M, Mirzaei H, Mahjoubin-Tehran M, Khanbabaei H Cancer Gene Ther. 2021; 28(12):1229-1255.

PMID: 33432087 DOI: 10.1038/s41417-020-00272-7.

The Long Noncoding RNA LOXL1-AS1 Promotes the Proliferation, Migration, and Invasion in Hepatocellular Carcinoma.

Liu J, Zhai C, Liu D, Liu J Anal Cell Pathol (Amst). 2020; 2020:4182092.

PMID: 33381389 PMC: 7759407. DOI: 10.1155/2020/4182092.

References

Mitra S, Mitra A, Triche T . A central role for long non-coding RNA in cancer. Front Genet. 2012; 3:17. PMC: 3279698. DOI: 10.3389/fgene.2012.00017. View

Lachenmayer A, Toffanin S, Cabellos L, Alsinet C, Hoshida Y, Villanueva A . Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J Hepatol. 2012; 56(6):1343-50. PMC: 3355195. DOI: 10.1016/j.jhep.2012.01.009. View

Panzitt K, Tschernatsch M, Guelly C, Moustafa T, Stradner M, Strohmaier H . Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132(1):330-42. DOI: 10.1053/j.gastro.2006.08.026. View

Zhang L, Yang F, Yuan J, Yuan S, Zhou W, Huo X . Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2012; 34(3):577-86. DOI: 10.1093/carcin/bgs381. View

Duong F, Christen V, Lin S, Heim M . Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology. 2010; 51(3):741-51. DOI: 10.1002/hep.23388. View

Esteller M . The necessity of a human epigenome project. Carcinogenesis. 2006; 27(6):1121-5. DOI: 10.1093/carcin/bgl033. View

Yoo Y, Na T, Seo H, Seong J, Park C, Shin Y . Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. 2008; 27(24):3405-13. DOI: 10.1038/sj.onc.1211000. View

Ozgur E, Mert U, Isin M, Okutan M, Dalay N, Gezer U . Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clin Exp Med. 2012; 13(2):119-26. DOI: 10.1007/s10238-012-0181-x. View

Tsai M, Spitale R, Chang H . Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011; 71(1):3-7. PMC: 3057914. DOI: 10.1158/0008-5472.CAN-10-2483. View

10.

Bots M, Johnstone R . Rational combinations using HDAC inhibitors. Clin Cancer Res. 2009; 15(12):3970-7. DOI: 10.1158/1078-0432.CCR-08-2786. View

11.

Engstrom P, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G . Complex Loci in human and mouse genomes. PLoS Genet. 2006; 2(4):e47. PMC: 1449890. DOI: 10.1371/journal.pgen.0020047. View

12.

Huynh H . Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol. 2010; 80(5):550-60. DOI: 10.1016/j.bcp.2010.03.034. View

13.

Dinger M, Amaral P, Mercer T, Pang K, Bruce S, Gardiner B . Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008; 18(9):1433-45. PMC: 2527704. DOI: 10.1101/gr.078378.108. View

14.

Marks P, Xu W . Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem. 2009; 107(4):600-8. PMC: 2766855. DOI: 10.1002/jcb.22185. View

15.

DU Y, Kong G, You X, Zhang S, Zhang T, Gao Y . Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012; 287(31):26302-11. PMC: 3406714. DOI: 10.1074/jbc.M112.342113. View

16.

Yang H, Bushue N, Bu P, Wan Y . Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells. Biochem Pharmacol. 2009; 79(7):948-54. PMC: 2832928. DOI: 10.1016/j.bcp.2009.11.004. View

17.

Moran V, Perera R, Khalil A . Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012; 40(14):6391-400. PMC: 3413108. DOI: 10.1093/nar/gks296. View

18.

Yang H, Nie Y, Li Y, Wan Y . Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells. Exp Biol Med (Maywood). 2010; 235(1):32-9. PMC: 3991239. DOI: 10.1258/ebm.2009.009252. View

19.

Li X, Wu Z, Fu X, Han W . Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases. Med Res Rev. 2012; 33(3):517-53. DOI: 10.1002/med.21254. View

20.

Yang F, Zhang L, Huo X, Yuan J, Xu D, Yuan S . Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011; 54(5):1679-89. DOI: 10.1002/hep.24563. View